In reviewing more than 600 cases of babies born to mothers with Zika, the researchers found “rashes in the third trimester of pregnancy were associated with brain abnormalities despite normal sized heads,” the paper reads. These infants showed no signs of obvious birth defect, but their brain scans showed they had characteristics comparable to those with congenital Zika virus infection. Additionally, the researchers suggest maternal history of a rash caused by Zika virus could be predictive of Zika virus congenital syndrome, even in cases where no apparent birth defect occurs.
“Because many definite or probable cases present normal head circumference values and their mothers do not report having a rash, screening criteria must be revised in order to detect all affected newborn babies,” the authors concluded.
More articles on Zika:
Math professors create model to better understand Zika sexual transmission
Researchers report successful Zika vaccine trial in mice
3 things to know about Zika research in primate labs
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
